Literature DB >> 25139064

Functional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior.

Marco Colizzi1, Leonardo Fazio2, Laura Ferranti3, Annamaria Porcelli2, Rita Masellis2, Daniela Marvulli2, Aurora Bonvino2, Gianluca Ursini4, Giuseppe Blasi2, Alessandro Bertolino5.   

Abstract

Cannabinoid signaling is involved in different brain functions and it is mediated by the cannabinoid receptor 1 (CNR1), which is encoded by the CNR1 gene. Previous evidence suggests an association between cognition and cannabis use. The logical interaction between genetically determined cannabinoid signaling and cannabis use has not been determined. Therefore, we investigated whether CNR1 variation predicts CNR1 prefrontal mRNA expression in postmortem prefrontal human tissue. Then, we studied whether functional variation in CNR1 and cannabis exposure interact in modulating prefrontal function and related behavior during working memory processing. Thus, 208 healthy subjects (113 males) were genotyped for the relevant functional SNP and were evaluated for cannabis use by the Cannabis Experience Questionnaire. All individuals performed the 2-back working memory task during functional magnetic resonance imaging. CNR1 rs1406977 was associated with prefrontal mRNA and individuals carrying a G allele had reduced CNR1 prefrontal mRNA levels compared with AA subjects. Moreover, functional connectivity MRI demonstrated that G carriers who were also cannabis users had greater functional connectivity in the left ventrolateral prefrontal cortex and reduced working memory behavioral accuracy during the 2-back task compared with the other groups. Overall, our results indicate that the deleterious effects of cannabis use are more evident on a specific genetic background related to its receptor expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25139064      PMCID: PMC4289952          DOI: 10.1038/npp.2014.213

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  51 in total

1.  Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up.

Authors:  Ruud van Winkel
Journal:  Arch Gen Psychiatry       Date:  2010-11-01

2.  AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.

Authors:  Ruud van Winkel; Nico J M van Beveren; Claudia Simons
Journal:  Neuropsychopharmacology       Date:  2011-07-20       Impact factor: 7.853

3.  Temporal dynamics and genetic control of transcription in the human prefrontal cortex.

Authors:  Carlo Colantuoni; Barbara K Lipska; Tianzhang Ye; Thomas M Hyde; Ran Tao; Jeffrey T Leek; Elizabeth A Colantuoni; Abdel G Elkahloun; Mary M Herman; Daniel R Weinberger; Joel E Kleinman
Journal:  Nature       Date:  2011-10-26       Impact factor: 49.962

4.  Paranoid schizophrenia is characterized by increased CB1 receptor binding in the dorsolateral prefrontal cortex.

Authors:  Victoria S Dalton; Leonora E Long; Cyndi Shannon Weickert; Katerina Zavitsanou
Journal:  Neuropsychopharmacology       Date:  2011-04-06       Impact factor: 7.853

Review 5.  The molecular genetics of executive function: role of monoamine system genes.

Authors:  Jessica J M Barnes; Angela J Dean; L Sanjay Nandam; Redmond G O'Connell; Mark A Bellgrove
Journal:  Biol Psychiatry       Date:  2011-03-11       Impact factor: 13.382

6.  Treatment with olanzapine is associated with modulation of the default mode network in patients with Schizophrenia.

Authors:  Fabio Sambataro; Giuseppe Blasi; Leonardo Fazio; Grazia Caforio; Paolo Taurisano; Raffaella Romano; Annabella Di Giorgio; Barbara Gelao; Luciana Lo Bianco; Apostolos Papazacharias; Teresa Popolizio; Marcello Nardini; Alessandro Bertolino
Journal:  Neuropsychopharmacology       Date:  2009-12-02       Impact factor: 7.853

7.  Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance.

Authors:  Alessandro Bertolino; Paolo Taurisano; Nicola Marco Pisciotta; Giuseppe Blasi; Leonardo Fazio; Raffaella Romano; Barbara Gelao; Luciana Lo Bianco; Madia Lozupone; Annabella Di Giorgio; Grazia Caforio; Fabio Sambataro; Artor Niccoli-Asabella; Audrey Papp; Gianluca Ursini; Lorenzo Sinibaldi; Teresa Popolizio; Wolfgang Sadee; Giuseppe Rubini
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

8.  COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in cannabis users.

Authors:  Antonio Verdejo-García; Ana Beatriz Fagundo; Aida Cuenca; Joan Rodriguez; Elisabet Cuyás; Klaus Langohr; Susana de Sola Llopis; Ester Civit; Magí Farré; Jordi Peña-Casanova; Rafael de la Torre
Journal:  Neuropsychopharmacology       Date:  2013-02-28       Impact factor: 7.853

Review 9.  Endocannabinoid system: An overview of its potential in current medical practice.

Authors:  Zadalla Mouslech; Vasiliki Valla
Journal:  Neuro Endocrinol Lett       Date:  2009       Impact factor: 0.765

10.  Dysregulation of working memory and default-mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC study.

Authors:  Dae Il Kim; Dara S Manoach; Daniel H Mathalon; Jessica A Turner; Maggie Mannell; Greg G Brown; Judith M Ford; Randy L Gollub; Tonya White; Cynthia Wible; Aysenil Belger; H Jeremy Bockholt; Vince P Clark; John Lauriello; Daniel O'Leary; Bryon A Mueller; Kelvin O Lim; Nancy Andreasen; Steve G Potkin; Vince D Calhoun
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

View more
  21 in total

Review 1.  Cannabinoids and Schizophrenia: Risks and Therapeutic Potential.

Authors:  Marc W Manseau; Donald C Goff
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

2.  Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson's disease.

Authors:  Jenny Ceccarini; Cindy Casteels; Rawaha Ahmad; Melissa Crabbé; Laura Van de Vliet; Heleen Vanhaute; Mathieu Vandenbulcke; Wim Vandenberghe; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-24       Impact factor: 9.236

3.  Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis.

Authors:  Marco Colizzi; Conrad Iyegbe; John Powell; Gianluca Ursini; Annamaria Porcelli; Aurora Bonvino; Paolo Taurisano; Raffaella Romano; Rita Masellis; Giuseppe Blasi; Craig Morgan; Katherine Aitchison; Valeria Mondelli; Sonija Luzi; Anna Kolliakou; Anthony David; Robin M Murray; Alessandro Bertolino; Marta Di Forti
Journal:  Schizophr Bull       Date:  2015-03-31       Impact factor: 9.306

Review 4.  Cannabinoid abuse and addiction: Clinical and preclinical findings.

Authors:  L V Panlilio; S R Goldberg; Z Justinova
Journal:  Clin Pharmacol Ther       Date:  2015-05-02       Impact factor: 6.875

5.  Genetic and Environmental Factors Associated with Cannabis Involvement.

Authors:  Ryan Bogdan; Jonathan Ma Winstone; Arpana Agrawal
Journal:  Curr Addict Rep       Date:  2016-04-12

6.  The interaction between cannabis use and a CB1-related polygenic co-expression index modulates dorsolateral prefrontal activity during working memory processing.

Authors:  Paolo Taurisano; Giulio Pergola; Anna Monda; Linda A Antonucci; Pasquale Di Carlo; Francesco Piarulli; Roberta Passiatore; Marco Papalino; Raffaella Romano; Alfonso Monaco; Antonio Rampino; Aurora Bonvino; Annamaria Porcelli; Teresa Popolizio; Roberto Bellotti; Alessandro Bertolino; Giuseppe Blasi
Journal:  Brain Imaging Behav       Date:  2021-02       Impact factor: 3.978

7.  Acute effects of Δ9-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity.

Authors:  Lisa-Marie Greenwood; Samantha J Broyd; Hendrika H van Hell; Juanita Todd; Alison Jones; Robin M Murray; Rodney J Croft; Patricia T Michie; Nadia Solowij
Journal:  Psychopharmacology (Berl)       Date:  2021-11-01       Impact factor: 4.530

8.  Neural mechanisms of sensitivity to peer information in young adult cannabis users.

Authors:  Jodi M Gilman; Randi M Schuster; Max T Curran; Vanessa Calderon; Andre van der Kouwe; A Eden Evins
Journal:  Cogn Affect Behav Neurosci       Date:  2016-08       Impact factor: 3.282

9.  MAP1B and NOS1 genes are associated with working memory in youths with attention-deficit/hyperactivity disorder.

Authors:  Angélica Salatino-Oliveira; Flávia Wagner; Glaucia C Akutagava-Martins; Estela M Bruxel; Júlia P Genro; Cristian Zeni; Christian Kieling; Guilherme V Polanczyk; Luis A Rohde; Mara H Hutz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-02       Impact factor: 5.270

10.  Neural Correlates of Social Influence Among Cannabis Users.

Authors:  Jodi M Gilman
Journal:  Curr Addict Rep       Date:  2017-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.